Shape Security
Appthority
Boundless
CTERA
Dollar Shave Club
Happier
Nest Labs
ADVANCE Medical
Appia
Dynamic Signal
FINsix
Hua Medicine
Klout
Kyruus
Personal Capital
Singly
BillFloat
PowerVision
Redbeacon (Home Depot)
Smartling
Ariosa Diagnostics
CloudFlare
Intuity Medical
Live Gamer
Media6Degrees
Mevion
Phononic Devices
Receptos
SocialShield (Avira)
AppNexus
Aria Systems
Awarepoint
Bizo
Castlight Health
Constellation Pharma
Crunchyroll
eIQnetworks
Fate Therapeutics
Gazelle
IP Commerce
Lavante
Martini Media
Sapphire Energy
SlideShare (LinkedIn)
Tudou (NASDAQ: TUDO)
World Heart (HeartWare)
Zeltiq (NASDAQ: ZLTQ)
Asoka
Atieva
BlogHer
Cerulean Pharma
CoreTrace
Good Technology
QuatRx Pharma
Semtek (VeriFone)
WHERE (eBay)
ADiFY (Cox Enterprises)
Adnexus (Bristol-Myers Squibb)
ApaceWave Technologies
B-hive Networks (VMware)
Boston-Power
ExtendMedia (Cisco)
PEAK Surgical (Medtronic)
Quantenna Communications
Transonic Combustion
Virgin Money
Alimera Sciences (NASDAQ: ALIM)
Ciclon Semiconductor (TI)
Ikaria
INRIX
Jadoo Power
Newport Media
Simple Star (Sonic Solutions)
Acceleron Pharma
Achaogen
BCD (NASDAQ: BCDS)
Celladon Corporation
CodeRyte (3M)
DATAllegro (Microsoft)
Metabolex
Neoconix
P.A. Semi (Apple)
RedSeal Networks
Retail Solutions
Trubion Pharma (NASDAQ: TRBN)
ZoomInfo
Anchor Bay Tech (Silicon Image)
Canesta (Microsoft)
Coley Pharma (Pfizer)
Imperva (NYSE: IMPV)
Intarcia Therapeutics
Sirna Therapeutics (Merck)
AVEO Pharma (NASDAQ: AVEO)
DataPower Technology (IBM)
Ensure Medical (Cordis)
IMlogic (Symantec)
MessageOne (Dell)
NanoGram (Wilson Greatbatch)
P-Cube (Cisco)
Pathwork Diagnostics
Pedestal Software (Altiris)
PGP (Symantec)
Vocera (NYSE: VCRA)
Vontu (Symantec)
WholeSecurity (Symantec)
Atrenta
FutureDial
Infinera (NASDAQ: INFN)
Infinity Pharma (NASDAQ: INFI)
Kineto Wireless
Nanosys
Spotlight Solutions (Oracle)
Vitae Pharma
Endeca Technologies (Oracle)
RelayHealth (McKesson)
Renovis (Evotec)
Syntonix Pharma (Biogen Idec)
Unicru (Kronos)
White Amber (Taleo)
Winery Exchange
XenoPort (NASDAQ: XNPT)
athenahealth (NASDAQ: ATHN)
Fogdog Sports (GSI Commerce)
GENBAND
Imaginova
Ironwood Pharma (NASDAQ: IRWD)
IVS (Abbott Labs)
ZettaCom (IDT)
2Wire (Pace)
Airspan Networks (NASDAQ: AIRN)
Authentica (EMC)
Castle Networks (Siemens)
Illumina (NASDAQ: ILMN)
Installation Software (Macrovision)
Memory Pharma (Roche)
Neoforma (Global HC Exchange)
Niku Corporation (CA Clarity)
Sunesis Pharma (NASDAQ: SNSS)
USInternetworking (AT&T)
CrossWorlds Software (IBM)
DoubleClick (Google)
Highground Systems (Sun Microsystems)
Icagen (Pfizer)
MediaMetrix (ComScore Networks)
Qpass (Amdocs)
Arris Networks (Ascend)
Caliper (NASDAQ: CALP)
Haystack Labs (Network Associates)
NetObjects (IBM)
New Oak (Bay Networks/Nortel)
ORATEC (Smith & Nephew)
Symyx (NASDAQ: SMMX)
WhoWhere? (Lycos)
Award Software (Phoenix Tech)
CardioThoracic (Guidant)
Check Point (NASDAQ: CHKP)
Dfx Interactive (Nvidia)
Digex (Intermedia Communications)
New Era of Networks (Sybase)
Ramp Networks (Nokia)
Sonic Innovations
Triangle Pharma (Gilead)
Idun Pharma (Pfizer)
ThermoSpectra (NYSE: TMO)
Anadys Pharma (NASDAQ: ANDS)
Med Partners (CVS)
Millennium Pharma (Takeda)
Signal Pharmaceuticals (Celgene)
Geron (NASDAQ: GERN)
Polycom (NASDAQ: PLCM)
Vical (NASDAQ: VICL)
EP Technologies (Boston Scientific)
HealthSouth (NYSE: HLS)
Pharmacyclics (NASDAQ: PCYC)
Spyglass (OpenTV)
SUGEN (Pharmacia & Upjohn)
Ligand Pharma (NASDAQ: LGND)
PerSeptive BioSystems (ABI)
Gilead Sciences (NASDAQ: GILD)
American Superconductor (NASDAQ: AMSC)
Mitek Products (Johnson & Johnson)
NovaCare (Select Medical)
TriQuint (NASDAQ: TQNT)
Athena Neurosciences (Elan)
Dianon Systems (LabCorp)
IDEC Pharma (Biogen)
SDRC (UGS)
StrataCom (Cisco)
Kopin (NASDAQ: KOPN)
Sepracor (NASDAQ: SEPR)
IDEXX Labs (NASDAQ: IDXX)
Sierra Semiconductor (PMC-Sierra)
Komag (Western Digital)
Sequent Computer
Cognex (NASDAQ: CGNX)
Liposome (Elan Pharma)
3Com (HP)
Mentor Graphics (NASDAQ: MENT)
Ungermann Bass (Tandem)
Apollo Computer (HP)
California Energy (IPO)
Centocor (Johnson & Johnson)
Genetics Institute (Wyeth)
VLSI Technology (Phillips)
Apple (NASDAQ: AAPL)
E&S (NASDAQ: ESCC)
Intel (NASDAQ: INTC)
Coherent (NASDAQ: COHR)
Thermo Electron (NYSE: TMO)
Fate Therapeutics is pioneering the emerging field of renewal therapies by redirecting the fate of the body’s adult stem cells to intervene in human disease, aberrant physiology or damaged tissue with “renewed” cellular health.
- Sector: Biopharmaceuticals
- Investment Status: Active
- Year Funded: 2008
Venrock Team
Bryan RobertsFate Therapeutics Live 
-
Fast Company lists Fate as one of 2011's top 10 innovators in biotech http://j.mp/g721BV via @FastCompany
11:34am February 18th from Fate Therapeutics -
Fast Company names Fate as part of 10 top innovators in biotech - FierceBiotech http://t.co/qlwWkdo
11:30am February 18th from Fate Therapeutics -
Whitehead member Rudolf Jaenisch honored for groundbreaking stem cell research http://fate.co/gFEhE3
5:26pm February 16th from Fate Therapeutics -
Also presenting 2/24 in San Francisco @CHI_Healthtech Molecular Med Tri-Con 2011 http://fate.co/dEP6qw
12:57pm February 9th from Fate Therapeutics -
General agenda posted for BIOCOM Global Life Science Partnering Conference http://fate.co/fUE091 (Fate presents 2/24 @ 11:15 am)
12:47pm February 9th from Fate Therapeutics -
Recipe For Turning Skin Cells Into Heart Cells | http://t.co/hWhKYIv #sciencefriday #listen @nprnews
5:05pm February 4th from Fate Therapeutics -
Science Friday Archives: Quicker Recipe For Turning Skin Cells Into Heart Cells http://t.co/3NfT5Ow
12:34pm February 3rd from Fate Therapeutics -
This is Your Year to Shine « 50th anniversary of the discovery of stem cells http://fate.co/faQTYX @cdnstemcell
4:52pm February 2nd from Fate Therapeutics -
Biologists grow beating heart cells from mice cells - Science Fair: USATODAY.com http://fate.co/fOPRCS
3:54pm January 31st from Fate Therapeutics -
Scripps Research scientists convert skin cells to beating heart cells http://t.co/xU17uH8
11:03am January 31st from Fate Therapeutics -
Scientists convert skin cells directly into beating heart cells http://www.bmedreport.com/archives/22667 #Ding
3:11pm January 30th from Fate Therapeutics -
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy http://dx.doi.org/10.1038/ncb2164
3:06pm January 30th from Fate Therapeutics -
Link to UCLA paper: An optimized small molecule inhibitor cocktail supports long-term maintenance of hESCs http://fate.co/i7Ks4c
2:27pm January 27th from Fate Therapeutics -
UCLA researchers eliminate major roadblock in regenerative medicine http://fate.co/hujFT6
2:17pm January 27th from Fate Therapeutics -
A tribute to Ernest McCulloch (1926-2011) « The Stem Cell Foundation Blog http://fate.co/eZb3pL
2:55pm January 24th from Fate Therapeutics -
The gourmet food tuck @Deviliciousfood is serving up lunch today across from Fate http://yfrog.com/h2a8vlzj
1:52pm January 14th from Fate Therapeutics -
Did you miss the Stem Cell Meeting on the Mesa 2010? Watch on The Science Network: http://fate.co/eW34Y4
1:55pm January 11th from Fate Therapeutics -
RT @Xconomy John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as http://t.co/IWd9nix
11:23am January 3rd from Fate Therapeutics
